Publikationen, an denen er mitarbeitet JOSE MANUEL VALDIVIELSO REVILLA (24)

2023

  1. Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial

    Nutrients, Vol. 15, Núm. 17

2022

  1. Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: An analysis from the NEFRONA cohort

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 4, pp. 663-672

2021

  1. Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort

    Nutrients, Vol. 13, Núm. 3, pp. 1-15

  2. Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain

    Advances in Therapy, Vol. 38, Núm. 10, pp. 5333-5344

  3. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054

2019

  1. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 619-630

  2. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  4. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2017

  1. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound

    PLoS ONE, Vol. 12, Núm. 10

  2. High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease

    Mediators of Inflammation, Vol. 2017

  3. The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. A new gender-specific formula to estimate 24-hour urine protein from protein to creatinine ratio

    Nephron, Vol. 133, Núm. 4, pp. 232-238

  2. Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD

    Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 2, pp. 287-296

  3. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396

  4. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia, Vol. 36, Núm. 4, pp. 389-396

2014

  1. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: Baseline data from the NEFRONA study

    BMC Nephrology, Vol. 15, Núm. 1

  2. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 29, Núm. 7, pp. 1415-1422

2013

  1. A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients

    BMC Nephrology, Vol. 14, Núm. 1

2011

  1. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis

    Clinical Journal of the American Society of Nephrology, Vol. 6, Núm. 2, pp. 303-310